AU2001259734A1 - Compounds and methods for regulating bacterial growth and pathogenesis - Google Patents

Compounds and methods for regulating bacterial growth and pathogenesis

Info

Publication number
AU2001259734A1
AU2001259734A1 AU2001259734A AU5973401A AU2001259734A1 AU 2001259734 A1 AU2001259734 A1 AU 2001259734A1 AU 2001259734 A AU2001259734 A AU 2001259734A AU 5973401 A AU5973401 A AU 5973401A AU 2001259734 A1 AU2001259734 A1 AU 2001259734A1
Authority
AU
Australia
Prior art keywords
pathogenesis
compounds
methods
bacterial growth
regulating bacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001259734A
Inventor
Bonnie L. Bassler
Carol S. Dammel
Stephan Schauder
Kevan Shokat
Jeffrey Stein
Michael G. Surette
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University Technologies International Inc
Quorex Pharmaceuticals Inc
Princeton University
Original Assignee
University Technologies International Inc
Quorex Pharmaceuticals Inc
Princeton University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Technologies International Inc, Quorex Pharmaceuticals Inc, Princeton University filed Critical University Technologies International Inc
Publication of AU2001259734A1 publication Critical patent/AU2001259734A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU2001259734A 2000-05-10 2001-05-10 Compounds and methods for regulating bacterial growth and pathogenesis Abandoned AU2001259734A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20300000P 2000-05-10 2000-05-10
US60/203,000 2000-05-10
US25439800P 2000-12-07 2000-12-07
US60/254,398 2000-12-07
PCT/US2001/015221 WO2001085664A2 (en) 2000-05-10 2001-05-10 Compounds and methods for regulating bacterial growth and pathogenesis

Publications (1)

Publication Number Publication Date
AU2001259734A1 true AU2001259734A1 (en) 2001-11-20

Family

ID=26898214

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001259734A Abandoned AU2001259734A1 (en) 2000-05-10 2001-05-10 Compounds and methods for regulating bacterial growth and pathogenesis

Country Status (5)

Country Link
US (3) US6559176B1 (en)
EP (1) EP1282415A2 (en)
JP (1) JP2003532698A (en)
AU (1) AU2001259734A1 (en)
WO (1) WO2001085664A2 (en)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7326542B2 (en) 1998-12-02 2008-02-05 Princeton University Compositions and methods for regulating bacterial pathogenesis
US6720415B2 (en) 1998-12-02 2004-04-13 Princeton University Compositions and methods for regulating bacterial pathogenesis
US6656703B1 (en) * 1999-12-29 2003-12-02 Millennium Pharamaceuticals, Inc. High throughput screen for inhibitors of fatty acid biosynthesis in bacteria
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
JP2003532698A (en) 2000-05-10 2003-11-05 プリンストン ユニバーシティ Compounds and methods for regulating bacterial growth and pathogenesis
AU2001261496A1 (en) * 2000-05-10 2001-11-20 Princeton University Luxo-sigma54 interactions and methods of use
US20030036091A1 (en) * 2000-10-03 2003-02-20 Lewis Hal A. Crystals and structure of LuxS
US6528472B2 (en) 2000-11-17 2003-03-04 S.C. Johnson & Son, Inc. Antimicrobial compositions containing quaternary ammonium compounds, silanes and other disinfectants with furanones
US7763769B2 (en) 2001-02-16 2010-07-27 Kci Licensing, Inc. Biocompatible wound dressing
US7700819B2 (en) 2001-02-16 2010-04-20 Kci Licensing, Inc. Biocompatible wound dressing
US7597895B2 (en) * 2001-02-20 2009-10-06 The Governing Council Of The University Of Toronto Signal peptides, nucleic acid molecules and methods for treatment of caries
WO2002085295A2 (en) * 2001-04-20 2002-10-31 The University Of Iowa Research Foundation Methods and compositions for the modulation of biofilm formation
AU2002322010A1 (en) * 2001-05-21 2002-12-03 Quorex Pharmaceuticals, Inc. Methods for regulating bacteria
US7575889B2 (en) 2001-05-22 2009-08-18 President And Fellows Of Harvard College Compound combinations for inhibiting cell division and methods for their identification and use
AUPR575401A0 (en) * 2001-06-18 2001-07-12 Unisearch Limited Method of causing sloughing
JP2005517635A (en) 2001-11-07 2005-06-16 フュアエスツェー アクチェンゲゼルシャフト Selective antibacterial agent
TW200400263A (en) * 2002-03-13 2004-01-01 Takara Bio Inc Effect of treatment with 4,5-dihydroxy-2-cyclopenten-1-one (DHCP) on gene expression and quorum-sensing in bacteria
DE50305726D1 (en) 2002-04-29 2007-01-04 Bayer Innovation Gmbh Method and device for detecting biologically active substances
DE10219031A1 (en) * 2002-04-29 2003-11-20 Bayer Ag Detecting biologically active compounds, useful for detecting toxins and in drug screening, based on their effect on luminescent bacteria
US7427408B2 (en) * 2002-06-06 2008-09-23 The Regents Of The University Of California Quorum sensing and biofilm formation
US7498292B2 (en) * 2002-08-15 2009-03-03 The Research Foundation Of State University Of New York Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
WO2004084973A2 (en) * 2003-03-24 2004-10-07 Becton, Dickinson And Company Invisible antimicrobial glove and hand antiseptic
ATE417052T1 (en) * 2003-09-02 2008-12-15 Yissum Res Dev Co OXAZABOROLIDINES AS BACTERIAL EFFECTORS
GB0326194D0 (en) * 2003-11-10 2003-12-17 Univ Kent Canterbury Proteins involved in signal transduction
GB0326192D0 (en) * 2003-11-10 2003-12-17 Univ Kent Canterbury Proteins involved in signal transduction
AU2004315890A1 (en) * 2003-12-04 2005-09-01 Burwell, Steve Mr. Methods and compositions for preventing biofilm formations, reducing existing biofilms, and for reducing existing biofilms, and for reducing populations of bacteria
DE10361457A1 (en) 2003-12-23 2005-07-28 Henkel Kgaa New alkoxylactones, alkoxylactams and alkoxythiolactams
WO2005072274A2 (en) * 2004-01-23 2005-08-11 The Trustees Of Princeton University Autoinducer-2 compounds as immunomodulatory agents
US7875598B2 (en) * 2004-03-04 2011-01-25 The Regents Of The University Of California Compositions useful for the treatment of microbial infections
US20060229259A1 (en) 2004-04-12 2006-10-12 Miller Stephen T AI-2 compounds and analogs based on Salmonella typhimurium LsrB structure
WO2005100544A2 (en) * 2004-04-12 2005-10-27 The Trustees Of Princeton University SMALL RNAs AND BACTERIAL STRAINS INVOLVED IN QUORUM SENSING
JP4806804B2 (en) * 2004-08-17 2011-11-02 株式会社片山化学工業研究所 Method for preventing microbial damage in sterilization target systems
WO2006073514A2 (en) * 2004-08-25 2006-07-13 Tufts University Compositions, methods and kits for repressing virulence in gram positive bacteria
US20100129349A1 (en) * 2004-08-26 2010-05-27 Heinrichs David E Methods of inhibiting staphylobactin-mediated iron uptake in S. aureus
US8729013B2 (en) 2004-08-26 2014-05-20 The University Of Western Ontario Methods of inhibiting staphylobactin-mediated iron uptake in S. aureus
JP5133067B2 (en) 2005-02-04 2013-01-30 ウイスコンシン アラムナイ リサーチ ファウンデーシヨン Compounds and methods for altering communication and toxicity in quorum sensing bacteria
US7312049B2 (en) * 2005-06-14 2007-12-25 The Board Of Trustees Of The Leland Stanford Junior University Total amino acid stabilization during cell-free protein synthesis
US20100311770A1 (en) * 2005-06-16 2010-12-09 President And Fellows Of Harvard College Compound combinations for inhibiting cell division and methods for their identification and use
US20070059414A1 (en) * 2005-09-13 2007-03-15 Novak John S Method and Process of Using Controlled Gas Environments to Inhibit Microbial Growth
US20090215079A1 (en) * 2005-12-05 2009-08-27 Technische Universitat Dresden Method and Devices for the Detection of Microorganisms and/or the Activity Thereof
US8512294B2 (en) * 2006-07-28 2013-08-20 Becton, Dickinson And Company Vascular access device antimicrobial materials and solutions
WO2008030988A2 (en) 2006-09-06 2008-03-13 The Regents Of The University Of California Selectively targeted antimicrobial peptides and the use thereof
US20100143972A1 (en) * 2006-12-14 2010-06-10 Horswill Alexander R Method of Making Cyclic Polypeptides with Inteins
WO2008088771A2 (en) * 2007-01-12 2008-07-24 Cornell Research Foundation, Inc. Adenylyl cyclases as novel targets for the treatment of infection by eukaryotic pathogens
CN101636157A (en) * 2007-01-12 2010-01-27 康乃尔研究基金会有限公司 Adenylyl cyclases as novel targets for antibacterial interventions
EP2136800A4 (en) * 2007-03-19 2011-10-05 Wisconsin Alumni Res Found Modulation of bacterial quorum sensing with synthetic ligands
DE112008001301T5 (en) * 2007-05-14 2010-04-29 Reserach Foundation Of State University Of New York Induction of a physiological dispersion response in bacterial cells in a biofilm
EP2155705A4 (en) * 2007-06-08 2012-02-15 Univ Georgia State Res Found Compositions for regulating or modulating quorum sensing in bacteria, methods of using the compounds, and methods of regulating or modulating quorum sensing in bacteria
US8663927B2 (en) * 2007-09-10 2014-03-04 University Of Kentucky Research Foundation Systems and methods for diagnosis and monitoring of bacteria-related conditions
WO2009088402A2 (en) * 2007-10-01 2009-07-16 Princeton University Identification of bacterial autoinducer and use in treating bacterial pathogenicity
JP5318521B2 (en) * 2007-10-17 2013-10-16 花王株式会社 Quantification method of auto inducer-2
CN104211775A (en) * 2007-10-25 2014-12-17 斯克利普斯研究院 Antibody-mediated disruption of quorum sensing in bacteria
EP2100602A1 (en) * 2008-03-12 2009-09-16 QuoNova Europe GmbH Method and compositions suitable for treatment of wounds
KR100868574B1 (en) 2008-03-17 2008-11-13 한국광해관리공단 Assessing biofilm formation onto natural soil particles
WO2009148571A1 (en) * 2008-06-02 2009-12-10 The Trustees Of Princeton University Inhibition of quorum sensing-mediated processes in bacteria
US8445190B2 (en) * 2008-09-30 2013-05-21 The Trustees Of The University Of Pennsylvania Method of inhibiting biomaterial-induced procoagulant activity using complement inhibitors
GB0818547D0 (en) * 2008-10-09 2008-11-19 Uni I Oslo Antimicrobial compositions and uses
US8647640B2 (en) * 2009-06-24 2014-02-11 Richard E. COWART Vaccine compositions and methods of use to protect against infectious disease
US8624063B2 (en) 2009-06-30 2014-01-07 Wisconsin Alumni Research Foundation Non-lactone carbocyclic and heterocyclic antagonists and agonists of bacterial quorum sensing
US8821455B2 (en) * 2009-07-09 2014-09-02 Becton, Dickinson And Company Antimicrobial coating for dermally invasive devices
WO2011012855A2 (en) * 2009-07-28 2011-02-03 Raymond Stanley Steggles Antibacterial compositions
US20110065798A1 (en) * 2009-09-17 2011-03-17 Becton, Dickinson And Company Anti-infective lubricant for medical devices and methods for preparing the same
JP2012097033A (en) * 2010-11-02 2012-05-24 Kao Corp Autoinducer-2 inhibitor
JP5946608B2 (en) * 2011-05-26 2016-07-06 花王株式会社 Autoinducer-2 inhibitor
US20140155589A1 (en) 2011-07-26 2014-06-05 Kurashiki Boseki Kabushiki Kaisha Inhibitory fiber against virulence factors production and method for producing same
US9695323B2 (en) 2013-02-13 2017-07-04 Becton, Dickinson And Company UV curable solventless antimicrobial compositions
US9750928B2 (en) 2013-02-13 2017-09-05 Becton, Dickinson And Company Blood control IV catheter with stationary septum activator
US9327095B2 (en) 2013-03-11 2016-05-03 Becton, Dickinson And Company Blood control catheter with antimicrobial needle lube
US9750927B2 (en) 2013-03-11 2017-09-05 Becton, Dickinson And Company Blood control catheter with antimicrobial needle lube
JP5827704B2 (en) * 2014-01-24 2015-12-02 花王株式会社 Periodontal disease marker
US9675793B2 (en) 2014-04-23 2017-06-13 Becton, Dickinson And Company Catheter tubing with extraluminal antimicrobial coating
US9789279B2 (en) 2014-04-23 2017-10-17 Becton, Dickinson And Company Antimicrobial obturator for use with vascular access devices
US10376686B2 (en) 2014-04-23 2019-08-13 Becton, Dickinson And Company Antimicrobial caps for medical connectors
US10232088B2 (en) 2014-07-08 2019-03-19 Becton, Dickinson And Company Antimicrobial coating forming kink resistant feature on a vascular access device
GB201511129D0 (en) 2015-06-24 2015-08-05 Linea Ab Q Method of determining antimicrobial susceptibility of a microorganism
CN105017209B (en) * 2015-07-07 2017-03-29 华东师范大学 A kind of 3 ketone compounds of polysubstituted dihydro-thiophene and its synthetic method
US10493244B2 (en) 2015-10-28 2019-12-03 Becton, Dickinson And Company Extension tubing strain relief
WO2017176807A2 (en) * 2016-04-04 2017-10-12 University Of Virginia Patent Foundation Compositions for inhibiting formation of and/or disrupting bacterial biofilms and methods of use therefor
NO342374B1 (en) * 2016-07-08 2018-05-14 Inhibio As Compounds and compositions for biofilm prevention
US10526278B2 (en) 2017-10-19 2020-01-07 Wisconsin Alumni Research Foundation Inhibitors of quorum sensing receptor LasR
EP3801582A4 (en) * 2018-06-08 2022-07-06 The Regents of the University of California Multistrain population control systems and methods
WO2023059224A1 (en) 2021-10-09 2023-04-13 Joint Stock Company "Pharmasyntez" A new class of antiviral drugs

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS179567B1 (en) 1974-11-25 1977-11-30 Vladimir Stoy Ionogennic hydrophilic in water insoluble gels based on partial saponificated polymers or copolymers acrylonitrile and method of preparing them
GB8414273D0 (en) 1984-06-05 1984-07-11 Oxoid Ltd Identifying streptococcal grouping
US4861709A (en) 1985-05-31 1989-08-29 Technicon Research A.G. Detection and/or identification of microorganisms in a test sample using bioluminescence or other exogenous genetically-introduced marker
US4917686A (en) 1985-12-16 1990-04-17 Colorado Biomedical, Inc. Antimicrobial device and method
US4895566A (en) 1986-07-25 1990-01-23 C. R. Bard, Inc. Coating medical devices with cationic antibiotics
US4846844A (en) 1987-08-31 1989-07-11 Eli Lilly And Company Antimicrobial coated implants
US5013306A (en) 1989-01-18 1991-05-07 Becton, Dickinson And Company Anti-infective and antithrombogenic medical articles and method for their preparation
US4891709A (en) * 1989-03-31 1990-01-02 Eastman Kodak Company Flexible formatting interface for pictorial data transfer
JPH03202609A (en) 1989-12-28 1991-09-04 Nissan Motor Co Ltd Engine exhaust emission control device
US5103306A (en) 1990-03-28 1992-04-07 Transitions Research Corporation Digital image compression employing a resolution gradient
US5196318A (en) 1990-06-26 1993-03-23 The Texas A&M University System Precisely regulated expression of deleterious genes
US6017722A (en) 1991-04-04 2000-01-25 Board Of Regents, The University Of Texas System Luminous bacteria and methods for the isolation, identification and quantitation of toxicants
GB9108307D0 (en) 1991-04-18 1991-06-05 Univ Nottingham Autoinducer
JPH06509712A (en) 1991-07-30 1994-11-02 バイオ−テクニカル・リソーシス Device for detecting impurities in water
US5591872A (en) 1993-08-09 1997-01-07 The University Of Iowa Research Foundation Autoinducer molecule
FI96697C (en) 1993-08-18 2001-05-16 Valio Oy New Streptococcus thermophilus strains and their use for antibiotic testing
US5788979A (en) 1994-07-22 1998-08-04 Inflow Dynamics Inc. Biodegradable coating with inhibitory properties for application to biocompatible materials
US5637113A (en) 1994-12-13 1997-06-10 Advanced Cardiovascular Systems, Inc. Polymer film for wrapping a stent structure
US5876791A (en) 1995-02-01 1999-03-02 Cal-West Equipment Co., Inc. Protective coating compositions and methods of use thereof
US5624704A (en) 1995-04-24 1997-04-29 Baylor College Of Medicine Antimicrobial impregnated catheters and other medical implants and method for impregnating catheters and other medical implants with an antimicrobial agent
US6020121A (en) 1995-09-29 2000-02-01 Microcide Pharmaceuticals, Inc. Inhibitors of regulatory pathways
US5759798A (en) * 1995-12-08 1998-06-02 Woods Hole Oceanographic Institution Assays, test kits and bacteria for detection of autoinducers
US5925552A (en) 1996-04-25 1999-07-20 Medtronic, Inc. Method for attachment of biomolecules to medical devices surfaces
EA003923B1 (en) 1996-09-27 2003-10-30 Такара Сузо Ко., Лтд Cyclopentenones, process for preparing the same, and the use thereof
JP3763585B2 (en) 1997-03-11 2006-04-05 タカラバイオ株式会社 Cyclopentenone derivative
ATE342661T1 (en) 1997-06-18 2006-11-15 Univ Montana State HOMOSERINE LACTONE FOR REGULATING BIOFILM AND METHODS OF APPLICATION
EA002354B1 (en) 1997-06-30 2002-04-25 Такара Сузо Ко., Лтд. Cyclopentenone derivatives
KR100532815B1 (en) 1997-07-02 2005-12-02 다카라 바이오 가부시키가이샤 Antiallergic agents
CA2313517A1 (en) 1997-12-11 1999-06-17 Takara Shuzo Co., Ltd. Substance for inducing apoptosis
PT1064298E (en) 1998-03-19 2009-01-02 Vertex Pharma Inhibitors of caspases
GB9814648D0 (en) * 1998-07-07 1998-09-02 Quest Int Sub-lethal perfumes
US6380262B1 (en) 1998-08-19 2002-04-30 Takara Shuzo Co., Ltd. 5-membered ring compounds
US6197591B1 (en) 1998-09-14 2001-03-06 Pfizer Inc. Streptomyces avermitilis regulatory genes for increased avermectin production
US7326542B2 (en) * 1998-12-02 2008-02-05 Princeton University Compositions and methods for regulating bacterial pathogenesis
US6720415B2 (en) * 1998-12-02 2004-04-13 Princeton University Compositions and methods for regulating bacterial pathogenesis
KR20010093800A (en) 1998-12-02 2001-10-29 유니버시티 테크놀로지스 인터내셔널 Compositions and Methods for Regulating Bacterial Pathogenesis
JP2003532698A (en) * 2000-05-10 2003-11-05 プリンストン ユニバーシティ Compounds and methods for regulating bacterial growth and pathogenesis

Also Published As

Publication number Publication date
WO2001085664A2 (en) 2001-11-15
US7666619B2 (en) 2010-02-23
US20040097402A1 (en) 2004-05-20
US6559176B1 (en) 2003-05-06
US20040180829A1 (en) 2004-09-16
US6780890B2 (en) 2004-08-24
EP1282415A2 (en) 2003-02-12
JP2003532698A (en) 2003-11-05
WO2001085664A8 (en) 2003-11-20
WO2001085664A3 (en) 2002-08-08

Similar Documents

Publication Publication Date Title
AU2001259734A1 (en) Compounds and methods for regulating bacterial growth and pathogenesis
AU2001234111A1 (en) Illuminator for plant growth
AU2722802A (en) Bacterial inoculants for enhancing plant growth
AUPR030900A0 (en) Growth factor complex
AU7472198A (en) Method for limiting the growth of microorganisms using metal-containing compounds
AU2001272408A1 (en) Growth promoter for animals
EP1135144A4 (en) Compositions and methods for regulating bacterial pathogenesis
AUPR209000A0 (en) Regulation of bacterial virulence
AU2003232173A1 (en) Compounds and methods for controlling bacterial virulence
AU2002222728A1 (en) Fertilizer containing excretions
AU2001238152A1 (en) Insecticidal compounds and methods for selection thereof
AU2001271890A1 (en) Methods for regulating beta-oxidation in plants
AU2001283322A1 (en) Organic nutrient for hair loss treatment
AU3075399A (en) Methods for regulating plants growth
AU2002322010A1 (en) Methods for regulating bacteria
AU2002246676A1 (en) Methods for determining organisms
AU2002213263A1 (en) Process for inhibiting the growth of microorganisms in a pesticide suspension
AU2001293961A1 (en) Suspended spool, in particular for cultivated plants
AU2002210518A1 (en) Aerobic fermentation method
AU2001230646A1 (en) Method for ventilating diggings
AU4547600A (en) Bacterial culture
AU2001252197A1 (en) Oxime derivatives for controlling undesired microorganisms and animal pests
AU2001262373A1 (en) Growth prediction device for plants
AU2001289571A1 (en) Plants having modified growth properties
AU2001286186A1 (en) Bacterial plant disease control composition